Phase 1 Dose Escalation and Randomized Phase 2 Trial of Carboplatin and Gemcitabine With or Without VX-970 in First Recurrence Platinum-Sensitive Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer
Phase of Trial: Phase I/II
Latest Information Update: 21 Mar 2018
At a glance
- Drugs M 6620 (Primary) ; Carboplatin; Gemcitabine
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 07 Mar 2017 Trial phase has been changed from phase II to phase I\II.
- 07 Mar 2017 Planned number of patients changed from 117 to 150.